FACT II terminates merger with Precision Aerospace & Defense

The immediate loser is the warrant line: once a de-SPAC path gets reset, the equity is still a claim on trust plus a new optionality event, but the warrants reprice as a cleaner wager on sponsor execution rather than a specific closing. That means FACTW should bleed fastest on every month of delay, especially if the market starts to assume a serial-SPAC discount for broken processes and weaker sponsor signaling.

For the common and units, the first-order damage is less about permanent capital impairment and more about time value destruction. The trust backstop keeps the downside more contained than the warrants, but a terminated deal raises the odds of extension fees, redemptions, and a lower-quality replacement target, which can force a wider discount to cash and increase borrow availability for shorts. In the SPAC complex, this is mildly positive for higher-quality sponsors that can still source deals; weaker vehicles face a tougher capital-raising environment because private targets will now demand better terms and more certainty.

The contrarian angle is that this is not automatically a liquidation event, so the market may over-penalize the common if investors conflate deal break with trust loss. If management quickly announces a credible replacement target, the common can mean-revert while the warrant remains structurally impaired. The key falsifier is a fast, financable replacement path within 1-3 months; absent that, the decay trade remains intact and the sponsor credibility hit compounds into the next extension cycle.